| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |